U
BDSI

UBS’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

UBS’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$163K Sell
9,512
-4,266
-31% -$61.9K ﹤0.01% 5420
2014
Q2 		$166K Buy
13,778
+7,878
+134% +$74.7K ﹤0.01% 5349
2014
Q1 		$50K Sell
5,900
-15,072
-72% -$122K ﹤0.01% 6847
2013
Q4 		$123K Buy
20,972
+4,755
+29% +$24.5K ﹤0.01% 5841
2013
Q3 		$88K Buy
16,217
+2,474
+18% +$11.9K ﹤0.01% 6161
2013
Q2 		$56K Buy
+13,743
New +$64.5K ﹤0.01% 6608

Other funds holding BDSI

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UBS's BDSI Position: Q3 2014 in Review

UBS reduced its BioDelivery Sciences International, Inc. (BDSI) stake by 31% in Q3 2014, selling an estimated $61.9K and leaving 9,512 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #5420.

UBS first reported a position in BDSI in Q2 2013 and has held it in 6 quarters since. The position peaked at $166K in Q2 2014. 116 funds tracked by Wall St. Rank hold BDSI as of Q3 2014.

  • UBS held 9,512 shares of BioDelivery Sciences International, Inc. worth $163K as of Q3 2014.
  • UBS sold 4,266 BioDelivery Sciences International, Inc. shares in Q3 2014, an estimated $61.9K.
  • BioDelivery Sciences International, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5420 holding.
  • UBS first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and has held it in 6 quarters since.
  • UBS's BioDelivery Sciences International, Inc. position peaked at $166K in Q2 2014.
  • 116 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.